作者: Zhongjun Fan , Qi Xu , Changhui Wang , Xiukun Lin , Quanbin Zhang
DOI: 10.1016/J.IJBIOMAC.2019.12.158
关键词:
摘要: Glioblastoma (GBM) represents the most common, aggressive and deadliest primary tumors with poor prognosis as available therapeutic approaches fail to control its aberrant proliferation and high invasiveness. Thus, the therapeutic agents targeting these two characteristics will be more effective. In present study, a novel polypeptide (MM15), which was originally purified from Meretrix meretrix Linnaeus and has been proven to possess potent antitumor activity by our laboratory, was recombinant expressed and identified as a …